Significantly improve the output and quality of your pharma R&D with automation and digitalization designed by chemists for chemists.
The pharmaceutical industry faces the increased demand for innovative, better, “rule of five compatible” medicines against various diseases.
Time-to-market of easily accessible and at the same time highly innovative API’s is essential.
Chemspeed provides high throughput and high output solutions which accelerate, standardize and digitize your R&D and quality control without compromise in areas such as:
Highly innovative technologies allow mimicking virtually any workflow in a fully automated way. This saves precious time and increases output and quality of your lab dramatically by using concepts designed for chemists by chemists.
63 solutions · Page 1 of 7
Molecular diversity / large-molecule discovery in e.g. medicinal chemistry enabled by our high throughput library synthesis solutions in disposable glass vials and / or reusable double-jacket reactors and / or microwave reactors and / or photochemical glass reactors. The leading technology in overhead gravimetric dispensing / dosing (patented) combined with our disposable glass reactors, and our user-friendly software, allow you to accelerate, standardize and digitalize your (oligo)peptide, (oligo)nucleotide and (oligo)saccharide workflows.
Chemspeed's FLEX POWDERDOSE with its proprietary overhead gravimetric solid dispensing / dosing (mg to g) and our user-friendly software allow you to automatically dispense virtually any powder / solid and extrudate into any type of destination.
Chemspeed's FLEX POWDERDOSE for versatile solid reagent filling into a vast range of recipients enabled by our unique overhead gravimetric dispensing of solids and automated decapping / capping.
Automated gravimetric solid dispensing / dosing - precision, accuracy, speed, data integrity (incl. applications in GMP environments).
Gravimetric pick & decision dispense of solids (matrix-to-matrix) - paradigm shift in solid / powder distribution / reformatting.
Step-change in end-to-end DSC sample preparation - gravimetric pick & decision dispense of solids / matrix-to-matrix reformatting.
Step-change in end-to-end NMR and LCMS sample preparation - gravimetric pick & decision dispense of solids / matrix-to-matrix reformatting, dissolution and online / offline NMR and / or LC-MS (incl. applications in GMP environments).
Paradigm shift in catalyst screening - gravimetric pick & dispense of ligands, catalyst precursors, catalysts.
Step-change in solid compound management - gravimetric pick & dispense of solids for e.g. biological screening.
Formulation screening enabled by fractional compositional mapping based on gravimetric pick & decision dispense of solids.
124 results · Page 1 of 21
The challenges posed by global climate change and disease risks have intensified the demand for efficient and practical materials and molecules. Traditional trial-and-error approaches are becoming increasingly inefficient and resource-intensive. The rapid advancement of artificial intelligence (AI) has opened new avenues to accelerate research and shorten development cycles.
Self-driving labs (SDLs) combine robotic automation with artificial intelligence (AI) to allow autonomous, high-throughput experimentation. However, robot manipulation in most SDL workflows operates in an open-loop manner, lacking real-time error detection and error correction. This can reduce reliability and overall efficiency.
Diverse collections of well-defined glycans are needed to investigate the molecular mechanisms by which these biomolecules mediate biological and disease processes. Several automation approaches have been introduced to accelerate the enzymatic synthesis of complex glycans. These methodologies have, however, provided only relatively simple oligosaccharides due to limitations of glycosyl transferase selectivity.
Pharmaceuticals increasing complexity requires longer synthesis with unique processes for each step, increasing the number of experiments to develop robust sustainable processes. The time to develop these processes is getting shorter, and automation can support the growing need to efficiently perform more experiments.
In modern pharmaceutical and bioprocess manufacturing environments, automation alone is no longer enough. True digital transformation requires every instrument, robot, sensor, and workflow to operate with precision, reliability, and complete data integrity.
Autonomous laboratories, also known as self-driving labs, have emerged as a powerful strategy to accelerate chemical discovery. By highly integrating different key parts including artificial intelligence (AI), robotic experimentation systems and automation technologies into a continuous closed-loop cycle, autonomous laboratories can efficiently conduct scientific experiments with minimal human intervention.
From innovation to quality, Chemspeed delivers automation & digitalization that grows with your lab.
Chemspeed is a global team committed to enable automated and digitalized workflows for scientists in R&D and QC.
© Chemspeed Technologies 2026